Literature DB >> 10084605

Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex.

C A Stratakis1, J A Carney, L S Kirschner, H S Willenberg, S Brauer, M Ehrhart-Bornstein, S R Bornstein.   

Abstract

Carney complex (CNC) is characterized by lentiginosis and myxomatosis together with a variety of endocrine, neural crest-derived, and other tumors, including primary pigmented nodular adrenocortical disease (PPNAD). PPNAD is characterized by lipofuscin-containing, autonomously functioning, cortisol-producing nodules surrounded by mostly atrophic adrenocortical and normal adrenomedullary tissue. The nature and origin of the tumors, including the myxomas and PPNAD, are unclear. In this study, seven paraffin-embedded PPNAD tumors, one skin myxoma, and two cell lines (one myxoma and one PPNAD) established from patients with CNC were stained with antisera for synaptophysin (SYN), neuron-specific enolase, chromogranin A, tyrosine hydroxylase, and the neural cell adhesion molecule (NCAM). In addition, one PPNAD specimen and one myxoma were analyzed by electron microscopy. The results showed that chromogranin A and tyrosine hydroxylase stained adrenomedullary tissue, but not the PPNAD nodules or the extranodular adrenal cortex. SYN, neuron-specific enolase, and NCAM also stained the medulla. PPNAD nodules and the PPNAD cell line, but not the extranodular adrenal cortex, stained intensely for SYN. The myxoma cell line, but not normal fibroblasts, stained for SYN and NCAM. Ultrastructural analysis of a PPNAD tumor and a skin myxoma revealed a well developed rough endoplasmic reticulum, prominent mitochondria, and vesicle-like structures dispersed throughout the cytoplasm. We conclude that immunostaining for SYN, a marker protein for neuroendocrine cells, clearly distinguishes PPNAD nodules from surrounding adrenocortical tissue and can be helpful in the detection of small nodules in apparently unaffected cortex. The cells of a cutaneous myxoma were also stained positive by two of the three neuroendocrine markers. Finally, both PPNAD and myxoma cells demonstrated ultrastructural features suggestive of neuroendocrine properties. These results support the previously suggested hypothesis that the genetic mechanism leading to CNC involves genes with a neuroendocrine role.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084605     DOI: 10.1210/jcem.84.3.5549

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.

Authors:  Francesco Fallo; Isabella Castellano; Celso E Gomez-Sanchez; Yara Rhayem; Catia Pilon; Valentina Vicennati; Donatella Santini; Valeria Maffeis; Ambrogio Fassina; Paolo Mulatero; Felix Beuschlein; Martin Reincke
Journal:  Endocrine       Date:  2017-04-12       Impact factor: 3.633

Review 2.  The cAMP pathway and the control of adrenocortical development and growth.

Authors:  Cyrille de Joussineau; Isabelle Sahut-Barnola; Isaac Levy; Emmanouil Saloustros; Pierre Val; Constantine A Stratakis; Antoine Martinez
Journal:  Mol Cell Endocrinol       Date:  2011-10-15       Impact factor: 4.102

Review 3.  Phosphodiesterases and adrenal Cushing in mice and humans.

Authors:  E Szarek; C A Stratakis
Journal:  Horm Metab Res       Date:  2014-09-18       Impact factor: 2.936

4.  Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.

Authors:  Julie Le Mestre; Céline Duparc; Yves Reznik; Fidéline Bonnet-Serrano; Philippe Touraine; Olivier Chabre; Jacques Young; Mari Suzuki; Mathilde Sibony; Françoise Gobet; Constantine A Stratakis; Gérald Raverot; Jérôme Bertherat; Hervé Lefebvre; Estelle Louiset
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

5.  c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.

Authors:  Kiran Nadella; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-10       Impact factor: 5.678

6.  PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Authors:  Zakariae Bram; Estelle Louiset; Bruno Ragazzon; Sylvie Renouf; Julien Wils; Céline Duparc; Isabelle Boutelet; Marthe Rizk-Rabin; Rossella Libé; Jacques Young; Dennis Carson; Marie-Christine Vantyghem; Eva Szarek; Antoine Martinez; Constantine A Stratakis; Jérôme Bertherat; Hervé Lefebvre
Journal:  JCI Insight       Date:  2016-09-22

Review 7.  cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.

Authors:  Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-02-26       Impact factor: 4.102

8.  Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.

Authors:  Zonggao Shi; Maria J Henwood; Peter Bannerman; Dalia Batista; Anelia Horvath; Marta Guttenberg; Constantine A Stratakis; Adda Grimberg
Journal:  Growth Horm IGF Res       Date:  2007-02-05       Impact factor: 2.372

Review 9.  Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin- independent Cushing syndrome).

Authors:  Constantine A Stratakis
Journal:  Endocr Dev       Date:  2008

10.  Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.

Authors:  Zakariae Bram; Paraskevi Xekouki; Estelle Louiset; Meg F Keil; Dimitrios Avgeropoulos; Christoforos Giatzakis; Maria Nesterova; Ninet Sinaii; Leo J Hofland; Rabia Cherqaoui; Hervé Lefebvre; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2014-02-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.